Loading provider…
Loading provider…
Hematology & Oncology Physician in Lincoln, NE
NPI: 1093934598Primary Practice Location
Nebraska Hematology-Oncology, PC
4004 Pioneer Woods Dr, Lincoln, NE
Primary Employer
Nebraska Hematology-Oncology, PC
yourcancercare.com
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 652 | 2,077 |
| 2 | 80053Blood test, comprehensive group of blood chemicals | 617 | 1,739 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 543 | 1,402 |
| 4 | 83615Lactate dehydrogenase (enzyme) level | 455 | 1,174 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 369 | 727 |
Authors: Daniel Catenacci, Patrick Boland, Joseph Chao, Susanna Ulahannan, Harry Yoon, Mohamad Sonbol, Faithlore Gardner
Journal: ESMO Open
Publication Date: 2022-08-24
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Authors: Priti Patel
Publication Date: 2020-05-28
Authors: Afsaneh Shirani, Rana Zabad, Olaf Stuve
Journal: J Cent Nerv Syst Dis
Publication Date: 2021-11-20
Lead Sponsor: Eli Lilly and Company
Collaborators: ARMO BioSciences
Intervention / Treatment: DRUG: Pembrolizumab, BIOLOGICAL: Pegilodecakin
Lead Sponsor: Eli Lilly and Company
Collaborators: ARMO BioSciences
Intervention / Treatment: DRUG: Nivolumab, BIOLOGICAL: Pegilodecakin
Lead Sponsor: Eli Lilly and Company
Collaborators: NSABP Foundation Inc
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Standard Adjuvant Endocrine Therapy